Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
CNY 5.68
(1.25%)
CNY 5.68
(1.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 602.01 Million CNY | 12.21% |
| 2022 | 536.48 Million CNY | 33.91% |
| 2021 | 400.63 Million CNY | 26.79% |
| 2020 | 315.96 Million CNY | 28.51% |
| 2019 | 245.86 Million CNY | 0.01% |
| 2018 | 245.83 Million CNY | 26.03% |
| 2017 | 195.05 Million CNY | 13.87% |
| 2016 | 171.3 Million CNY | 51.59% |
| 2015 | 113 Million CNY | -17.62% |
| 2014 | 137.18 Million CNY | -25.81% |
| 2013 | 184.91 Million CNY | 22.44% |
| 2012 | 151.02 Million CNY | -25.64% |
| 2011 | 203.1 Million CNY | -7.44% |
| 2010 | 219.42 Million CNY | 8.23% |
| 2009 | 202.73 Million CNY | 130.02% |
| 2008 | 88.13 Million CNY | 103.49% |
| 2007 | 43.31 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 456.03 Million CNY | -8.64% |
| 2024 Q3 | 390.77 Million CNY | -14.31% |
| 2024 Q1 | 499.14 Million CNY | -17.09% |
| 2023 Q3 | 674.94 Million CNY | -11.78% |
| 2023 Q2 | 765.07 Million CNY | 7.9% |
| 2023 FY | 602.01 Million CNY | 12.21% |
| 2023 Q1 | 709.03 Million CNY | 32.16% |
| 2023 Q4 | 602.01 Million CNY | -10.81% |
| 2022 Q4 | 536.48 Million CNY | 8.51% |
| 2022 Q2 | 357.85 Million CNY | 11.34% |
| 2022 FY | 536.48 Million CNY | 33.91% |
| 2022 Q1 | 321.39 Million CNY | -19.78% |
| 2022 Q3 | 494.41 Million CNY | 38.16% |
| 2021 Q3 | 404.82 Million CNY | -3.17% |
| 2021 Q1 | 416.44 Million CNY | 31.8% |
| 2021 FY | 400.63 Million CNY | 26.79% |
| 2021 Q4 | 400.63 Million CNY | -1.04% |
| 2021 Q2 | 418.06 Million CNY | 0.39% |
| 2020 Q2 | 301.02 Million CNY | -19.45% |
| 2020 Q4 | 315.96 Million CNY | 23.59% |
| 2020 Q1 | 373.7 Million CNY | 52.0% |
| 2020 FY | 315.96 Million CNY | 28.51% |
| 2020 Q3 | 255.66 Million CNY | -15.07% |
| 2019 Q1 | 246.89 Million CNY | 0.43% |
| 2019 Q4 | 245.86 Million CNY | -23.17% |
| 2019 Q3 | 319.99 Million CNY | 42.53% |
| 2019 Q2 | 224.5 Million CNY | -9.07% |
| 2019 FY | 245.86 Million CNY | 0.01% |
| 2018 Q3 | 216.64 Million CNY | -2.05% |
| 2018 FY | 245.83 Million CNY | 26.03% |
| 2018 Q2 | 221.17 Million CNY | 29.64% |
| 2018 Q1 | 170.6 Million CNY | -12.54% |
| 2018 Q4 | 245.83 Million CNY | 13.47% |
| 2017 Q3 | 204.23 Million CNY | -14.44% |
| 2017 Q1 | 177.91 Million CNY | 3.86% |
| 2017 FY | 195.05 Million CNY | 13.87% |
| 2017 Q2 | 238.7 Million CNY | 34.17% |
| 2017 Q4 | 195.05 Million CNY | -4.49% |
| 2016 Q2 | 99.03 Million CNY | -3.58% |
| 2016 FY | 171.3 Million CNY | 51.59% |
| 2016 Q1 | 102.71 Million CNY | -9.1% |
| 2016 Q3 | 144.54 Million CNY | 45.95% |
| 2016 Q4 | 171.3 Million CNY | 18.51% |
| 2015 Q4 | 113 Million CNY | -9.84% |
| 2015 Q3 | 125.34 Million CNY | -18.49% |
| 2015 FY | 113 Million CNY | -17.62% |
| 2015 Q1 | 141.9 Million CNY | 3.44% |
| 2015 Q2 | 153.78 Million CNY | 8.37% |
| 2014 Q3 | 137.89 Million CNY | -4.28% |
| 2014 FY | 137.18 Million CNY | -25.81% |
| 2014 Q4 | 137.18 Million CNY | -0.52% |
| 2014 Q2 | 144.05 Million CNY | 7.91% |
| 2014 Q1 | 133.5 Million CNY | -27.8% |
| 2013 Q3 | 179.31 Million CNY | 33.47% |
| 2013 Q4 | 184.91 Million CNY | 3.12% |
| 2013 FY | 184.91 Million CNY | 22.44% |
| 2013 Q1 | 112.35 Million CNY | -25.61% |
| 2013 Q2 | 134.34 Million CNY | 19.57% |
| 2012 Q3 | 181.85 Million CNY | 4.92% |
| 2012 FY | 151.02 Million CNY | -25.64% |
| 2012 Q1 | 149.02 Million CNY | -26.63% |
| 2012 Q2 | 173.33 Million CNY | 16.31% |
| 2012 Q4 | 151.02 Million CNY | -16.95% |
| 2011 Q2 | 135.41 Million CNY | 1.47% |
| 2011 FY | 203.1 Million CNY | -7.44% |
| 2011 Q1 | 133.45 Million CNY | -39.18% |
| 2011 Q3 | 212.01 Million CNY | 56.57% |
| 2011 Q4 | 203.1 Million CNY | -4.2% |
| 2010 Q3 | 159.55 Million CNY | -9.28% |
| 2010 FY | 219.42 Million CNY | 8.23% |
| 2010 Q2 | 175.87 Million CNY | 0.0% |
| 2010 Q4 | 219.42 Million CNY | 37.52% |
| 2009 FY | 202.73 Million CNY | 130.02% |
| 2009 Q4 | 202.73 Million CNY | 0.0% |
| 2008 FY | 88.13 Million CNY | 103.49% |
| 2007 FY | 43.31 Million CNY | 0.0% |